PD-1/PD-L1 inhibitors in advanced, unresectable esophageal squamous-cell carcinoma: A meta-analysis of their effects across patient subgroups.
- DOI
- 10.1016/j.critrevonc.2025.104876
- Published
- 2025 Nov
- Container
- Critical reviews in oncology/hematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.critrevonc.2025.104876,
title = {PD-1/PD-L1 inhibitors in advanced, unresectable esophageal squamous-cell carcinoma: A meta-analysis of their effects across patient subgroups.},
author = {Beshr MS and Shembesh RH and Salama AH and Chenfouh I and Alfaqaih SM and Khashan A and Kara AO and Abuajamieh M and Basheer E and Ansaf ZA and Arhaym E and Nounou MV and Ali ME and Smyth EC and Elhadi M and Moehler M},
year = {2025},
journal = {Critical reviews in oncology/hematology},
doi = {10.1016/j.critrevonc.2025.104876},
url = {https://doi.org/10.1016/j.critrevonc.2025.104876}
}RIS
TY - JOUR TI - PD-1/PD-L1 inhibitors in advanced, unresectable esophageal squamous-cell carcinoma: A meta-analysis of their effects across patient subgroups. AU - Beshr MS AU - Shembesh RH AU - Salama AH AU - Chenfouh I AU - Alfaqaih SM AU - Khashan A AU - Kara AO AU - Abuajamieh M AU - Basheer E AU - Ansaf ZA AU - Arhaym E AU - Nounou MV AU - Ali ME AU - Smyth EC AU - Elhadi M AU - Moehler M PY - 2025 JO - Critical reviews in oncology/hematology DO - 10.1016/j.critrevonc.2025.104876 UR - https://doi.org/10.1016/j.critrevonc.2025.104876 ER -
APA
MS, B., RH, S., AH, S., I, C., SM, A., A, K., AO, K., M, A., E, B., ZA, A., E, A., MV, N., ME, A., EC, S., M, E., & M, M. (2025). PD-1/PD-L1 inhibitors in advanced, unresectable esophageal squamous-cell carcinoma: A meta-analysis of their effects across patient subgroups.. Critical reviews in oncology/hematology. https://doi.org/10.1016/j.critrevonc.2025.104876
Source records
- pubmed · retrieved 2026-09-26T06:26:51.198Z